Vivek Verma

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Metabolic Syndrome

Top Venues

Cancer reports (Hoboken, N.J.)

Nature immunology

Cancer immunology research

Journal for immunotherapy of cancer

Georgetown Lombardi Comprehensive Cancer Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Georgetown Lombardi Comprehensive Cancer Center Jan 01 2018

United States

Assistant Professor :: Department of Oncology

Publications

Kristin G Anderson, David A Braun, Aitziber Buque, Sarah B Gitto, Jennifer L Guerriero, Brendan L Horton, Bridget P Keenan, Teresa S Kim, Abigail Overacre-Delgoffe, Marco Ruella, Todd A Triplett, Omkara Veeranki, Vivek Verma, Fan Zhang
Leveraging immune resistance archetypes in solid cancer to inform next-generation anticancer therapies. Journal for immunotherapy of cancer 11 (6) (2023)
Rahul Nandre, Vivek Verma, Pankaj Gaur, Veerupaxagouda Patil, Xingdong Yang, Zainab Ramlaoui, Nour Shobaki, Mads Hald Andersen, Ayako Wakatsuki Pedersen, Mai-Britt Zocca, Mikayel Mkrtichyan, Seema Gupta, Samir N Khleif
IDO Vaccine Ablates Immune-Suppressive Myeloid Populations and Enhances Antitumor Effects Independent of Tumor Cell IDO Status. Cancer immunology research 10 (5) (2022)
Fabia de Oliveira Andrade, Vivek Verma, Leena Hilakivi-Clarke
Maternal obesity and resistance to breast cancer treatments among offspring: Link to gut dysbiosis. Cancer reports (Hoboken, N.J.) (2022)
Vivek Verma, Nazli Jafarzadeh, Shannon K Boi, Subhadip Kundu, Zhinuo Jiang, Yiping Fan, Jose Lopez, Rahul Nandre, Peng Zeng, Fatmah Alolaqi, Shamim Ahmad, Pankaj Gaur, Simon T Barry, Viia E Valge-Archer, Paul D Smith, Jacques F Banchereau, Mikayel Mkrtichyan, Benjamin A Youngblood, Paulo C Rodriguez, Seema Gupta, Samir N Khleif
MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects. Nature immunology 22 (1) (2020)